Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Euro Surveill. 2008 Apr 10;13(15). doi: 10.2807/ese.13.15.18834-en

Table 2.

Characteristics of European epidemiological surveillance programmes for toxoplasmosis. Eurotoxo, 2007

Country Year started Population under surveillance Case definition Reporting sources Frequency of analysis Frequency of surveillance reports Surveillance report distribution
Surveillance systems specifically dedicated to congenital toxoplasmosis
Denmark 1999 Live newborns Detection of IgM on blood filter sample confirmed by IgA, IgM and IgG profile in newborn and mother Statens Serum Institut NA Annually Healthcare authorities
France 2007 Foetuses, newborns and infants PCR, mouse inoculation, cell culture or immunocytochemistry on body tissues or fluids; detection of specific IgM or IgA antibodies; neosynthesis of specific IgG, IgM or IgA antibodies.; persistence of IgG until one year of age Laboratories qualified for antenatal or postnatal diagnosis NA NA Healthcare authorities
Germany NA Live newborns and infants Detection of Toxoplasma gondii in body tissues or fluids; detection of specific IgM or IgA antibodies; persistently stable specific IgG titres or a single elevated specific IgG titre Laboratories Continuous Quarterly and annually Free access on the Website of the Robert Koch Institute
Italy* 1997 Live newborns Persistence of IgG until one year of age Social workers
Paediatricians
Neonatalogists
Annually Annually National Health Institute, physicians, Regional Public Health Surveillance on Infectious Diseases
Surveillance systems dedicated to toxoplasmosis (congenital or not)
Bulgaria NA All EU (notifiable disease) Physicians
Laboratories
Epidemiologists
Annually Monthly and annually Ministry of Health
National Centre of Health Information
National Centre of Infectious and Parasitic Diseases
Cyprus 2004 All EU (notifiable disease) All registered medical practitioners Weekly Twice a year Physicians
Czech Republic 1970 All EU (notifiable disease) Epidemiologists Monthly Monthly and annually Epidemiologists, Physicians
Laboratories
England and Wales 1975 All EU (notifiable disease) Toxoplasma Reference Unit Swansea Monthly Quarterly and annually Electronic distribution (http://www.hpa.org.uk/hpr)
Estonia 1997 All EU (notifiable disease) General practitioners
Laboratories
Monthly Monthly and annually Health protection Inspectorate and Ministry of Social Affairs
Ireland 2004 All EU (notifiable disease) All registered medical practitioners
Laboratories
Weekly and annually Weekly and annually Physicians, Public health departments and population (Website)
Latvia 1995 All EU (notifiable disease) Physicians
Epidemiologists
Annually Monthly and annually Ministry of Health, Physicians
Lithuania 1992 All EU (notifiable disease) All registered medical practitioners Monthly and annually Monthly and annually Territorial healthcare institutions, Ministry of Health, European surveillance networks, WHO
Malta 2004 All EU (notifiable disease) Physicians
Laboratories
Continuous Weekly, monthly and annually Physicians, Ministry of Health, WHO
Poland 1966 All EU (notifiable disease) Physicians Occasionally Quarterly and annually Public administrations, research institutions sanitary stations
Scotland 1988 All EU (notifiable disease) Laboratories Continuous Available on Website Free access for all (on demand)
Slovakia 1975 All EU (notifiable disease) Physicians Monthly and annually Monthly and annually Physicians, Ministry of Health

NA: Not available; WHO: World Health Organization;

Inline graphic

as defined by the European Union4

*

Regional surveillance system (Campania country)

Inline graphic

Distinction between acquired and congential toxoplasmosis since 1999

Distinction between acquired and congential toxoplasmosis since 1997.